Profile data is unavailable for this security.
About the company
Shandong Buchang Pharmaceuticals Co Ltd is a China-based company primarily engaged in the research, development, production and sale of traditional Chinese medicine. The Company operates primarily through three segments. The Pharmaceuticals segment is engaged in the research, development and manufacturing of traditional Chinese medicine, chemical drugs and biological drugs for the cardiovascular, gynecological, urological, digestive and respiratory systems. The Pharmaceutical Sales segment is primarily engaged in the sales of pharmaceuticals. The Others segment is primarily engaged in the research, development and sales of vaccines and medical devices.
- Revenue in CNY (TTM)10.96bn
- Net income in CNY1.66m
- Incorporated2001
- Employees7.69k
- LocationShandong Buchang Pharmaceuticals Co LtdNo. 369Zhonghua West Road, Mudan DistrictHEZE 274000ChinaCHN
- Phone+86 5 305299167
- Fax+86 5 305299286
- Websitehttps://www.buchang.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tonghua Dongbao Pharmaceutical Co Ltd | 2.74bn | 1.23bn | 17.04bn | 3.41k | 13.87 | 2.39 | -- | 6.22 | 0.6271 | 0.6271 | 1.40 | 3.64 | 0.3589 | 1.05 | 5.11 | 803,924.60 | 15.84 | 14.89 | 17.08 | 15.68 | 71.05 | 78.86 | 44.15 | 35.26 | 3.49 | -- | 0.0988 | 50.60 | -34.66 | -6.27 | -103.66 | -- | 14.17 | 4.56 |
| Jinyu Bio-Technology Co Ltd | 1.33bn | 100.76m | 17.24bn | 1.74k | 218.45 | 3.15 | -- | 12.99 | 0.071 | 0.071 | 1.27 | 4.92 | 0.1946 | 2.45 | 1.89 | 762,676.30 | 1.37 | 4.31 | 1.56 | 5.06 | 50.46 | 57.76 | 7.02 | 17.99 | 3.09 | -- | 0.0029 | 36.89 | -21.45 | 2.19 | -61.57 | -13.19 | -21.84 | -12.94 |
| Shandong Buchang Pharmaceuticals Co Ltd | 10.96bn | 1.66m | 17.80bn | 7.69k | 2,475.07 | 1.68 | -- | 1.62 | 0.0068 | 0.0068 | 10.34 | 10.03 | 0.5519 | 0.9196 | 13.73 | 1,425,409.00 | -0.6503 | 0.8521 | -0.9366 | 1.25 | 62.31 | 70.57 | -1.18 | 1.32 | 0.4929 | 3.23 | 0.2758 | 157.32 | -16.91 | -5.04 | -273.62 | -- | -21.53 | -- |
| Liaoning Cheng Da Co Ltd | 11.12bn | 862.79m | 17.88bn | 3.32k | 20.33 | 0.6079 | -- | 1.61 | 0.575 | 0.575 | 7.27 | 19.23 | 0.2277 | 5.72 | 5.88 | 3,352,748.00 | 2.94 | 3.15 | 4.13 | 4.55 | 12.07 | 13.95 | 12.89 | 9.88 | 0.9357 | -- | 0.2586 | 16.44 | 4.70 | -8.65 | -10.09 | -29.33 | -9.31 | -27.52 |
| China Resources Dubl-Crne Phrmctl Co Ltd | 10.95bn | 1.58bn | 19.02bn | 13.41k | 11.95 | 1.68 | -- | 1.74 | 1.53 | 1.53 | 10.62 | 10.90 | 0.6524 | 2.99 | 5.05 | 816,058.20 | 9.70 | 8.90 | 13.45 | 11.99 | 56.61 | 57.39 | 14.86 | 13.13 | 1.75 | -- | 0.0904 | 33.53 | -0.8711 | 3.63 | -2.19 | 9.06 | 21.41 | 9.15 |
| BrightGene Bio-Medical Technology Co Ltd | 1.18bn | 62.08m | 19.18bn | 1.15k | 304.44 | 7.84 | -- | 16.26 | 0.1489 | 0.1489 | 2.82 | 5.79 | 0.2305 | 1.61 | 3.38 | 1,025,174.00 | 0.5058 | 5.25 | 0.6383 | 6.47 | 51.53 | 56.22 | 2.19 | 17.55 | 0.9402 | 1.23 | 0.4935 | 21.32 | 8.74 | 20.58 | -6.57 | 11.23 | 23.50 | 3.20 |
Data as of Feb 13 2026. Currency figures normalised to Shandong Buchang Pharmaceuticals Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
3.12%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| China Southern Asset Management Co., Ltd.as of 30 Jun 2025 | 8.49m | 0.77% |
| China Asset Management Co., Ltd.as of 30 Jun 2025 | 6.02m | 0.54% |
| Yinhua Fund Management Co., Ltd.as of 30 Jun 2025 | 5.29m | 0.48% |
| GF Fund Management Co., Ltd.as of 30 Jun 2025 | 3.34m | 0.30% |
| China Universal Asset Management Co., Ltd.as of 30 Jun 2025 | 3.26m | 0.30% |
| The Vanguard Group, Inc.as of 31 Dec 2025 | 2.78m | 0.25% |
| Fullgoal Fund Management Co., Ltd.as of 30 Jun 2025 | 1.40m | 0.13% |
| CCB Principal Asset Management Co., Ltd.as of 30 Jun 2025 | 1.39m | 0.13% |
| Shanghai Guotai Junan Securities Assets Management Co., Ltd.as of 30 Jun 2025 | 1.28m | 0.12% |
| Tian Hong Asset Management Co., Ltd.as of 30 Jun 2025 | 1.22m | 0.11% |
More ▼
Data from 30 Jun 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
